Inovio To Start Global Late-Stage COVID-19 Vaccine Trial

Inovio To Start Global Late-Stage COVID-19 Vaccine Trial

Source: 
Benzinga
snippet: 

The regulatory authority of Brazil has signed off Inovio Pharmaceuticals Inc's global Phase 3 segment of its INNOVATE Phase 2/3 trial for INO-4800, DNA COVID-19 vaccine candidate.